Probi has recruited Peter Nählstedt as its new CEO. Peter Nählstedt has extensive experience from the international Life Science industry through various executive positions involving strategy, marketing and sales at GE Healthcare Life Science. Peter Nählstedt joins Probi from Trelleborg Marine Systems where he has been responsible for operations in Europe, South America and North Africa. Nählstedt will assume his new position on 7 January 2014. Gun -Britt Fransson, who has been Acting CEO since the end of May 2013, will continue in her role as Vice President Research and Development and member of Probi’s management group. In 2010, Peter Nählstedt was recruited to Trelleborg Marine Systems to take responsibility for operations in Europe, South America and North Africa. Prior to this, he spent eight years at GE Healthcare, where he was General Manager Sales and Marketing for Bioprocess in North America between 2007 and 2010 and before that Strategic Marketing Director. During his time at GE Healthcare, Peter held various global executive positions with a focus on strategy, marketing and sales. He also worked with sales and marketing at Sigma Aldrich, a leading manufacturer of high technological products for life science research. “With the recruitment of Peter Nählstedt, we gain an individual with a solid strategic and international business background which, combined with Probi’s strong management team, will propel Probi into the next phase of its development in the form of continued expansion and further broadening of the operation, primarily in the international market,” says Per Lundin, Chairman of the Board of Probi. “Probi is currently in a phase of expansion with investments in Research and Development and in continued growth. The company has an excellent base for expansion through its clinically documented probiotic products and patented technology. I look forward to working with new distribution solutions and proprietary brands, as well as intensive business development in selected markets, such as the US, Eastern Europe and Asia,” says Peter Nählstedt. This information is such that Probi AB is required to disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. FOR MORE INFORMATION, PLEASE CONTACT: Per Lundin, Chairman of the Board, Tel: +46 (0)705-741171, e-mail: per.lundin@transit.se Peter Nählstedt, forthcoming CEO, Tel: +46 (0)706-848386 ABOUT PROBI Probi is a leading player in probiotic research and the development of efficient and well-documented probiotics. Its research areas include: gastrointestinal tracts, immune system, metabolic syndrome and stress and recovery. Probi’s customers are leading companies in the Functional Food and Consumer Healthcare segments. Total income for 2012 totalled MSEK 100.4. Probi’s share is listed on the NASDAQ OMX Stockholm, Small Cap. Probi has approximately 5,000 shareholders. Read more at på www.probi.se.
Probi recruits new CEO Probi has recruited Peter Nhlstedt
Top 10 Most Recent News Articles
Faith and Resilience in China: The Legacy of the Long March
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Lundbeck's Board Leadership Transitions into New Era
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
UEG's New Advisory Board: Elevating Patient Voices
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue ReadingTop 5 Most Recently Viewed Articles
Thermo Fisher's Role as the Leading Partner in Biopharma
Thermo Fisher's Role in Revolutionizing Biopharma Thermo Fisher Scientific Inc. (TMO) is increasingly becoming the cornerstone of the biopharma sector. Although some analysts have observed a recent dip in its stock performance, there is a strong belief in its capability to rebound through strategic acquisitions and promising growth prospects. Notably, Thermo Fisher boasts...
Continue Reading
Jamf Unveils Comprehensive Reinvestment Strategy for Growth
Jamf's Strategic Reinvestment Initiative In a bold move aimed at enhancing operational efficiency and shareholder value, Jamf (NASDAQ: JAMF) has announced a strategic reinvestment plan designed to propel long-term growth. This initiative comes on the heels of a comprehensive systems update that has illuminated new business opportunities and operational insights. Enhancing...
Continue Reading
Fidelity D & D Bancorp, Inc. Sees Earnings Impact in Q3
Fidelity D & D Bancorp, Inc. Announcements on Financial Standing In recent news regarding Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC), the company revealed its latest financial results, marking a significant quarter in their ongoing operations. As of September 30, 2024, Fidelity Bank, under the leadership of President and CEO Daniel J. Santaniello, has recorded key...
Continue Reading
Deutsche Bank Lowers Boeing Price Target, Retains Buy Rating
Deutsche Bank's Strategic Assessment of Boeing Recently, Deutsche Bank has made headlines with its updated financial outlook for Boeing (NYSE: BA), decreasing the stock price target from $225.00 to $195.00. However, they have maintained a Buy rating on the aerospace company's shares. This adjustment comes in response to expected larger free cash flow (FCF) burn for the...
Continue Reading
TIGRIS Aquatic Services Expands With LakePro Acquisition
TIGRIS Aquatic Services Expands With LakePro Acquisition TIGRIS Aquatic Services, LLC has made a significant move by acquiring LakePro, Inc., a prominent player in the field of aquatic management. This acquisition opens new opportunities for TIGRIS, expanding its operational reach into fresh markets and reinforcing its commitment to creating safe and well-managed water...
Continue Reading